Immunosuppressive Drug Azathioprine Reduces Aneurysm Progression Through Inhibition of Rac1 and c-Jun-Terminal-N-Kinase in Endothelial Cells
Author(s) -
Goran Marinković,
Stijntje Hibender,
Mark Hoogenboezem,
Amber van Broekhoven,
A F Girigorie,
Natascha Bleeker,
Anouk A.J. Hamers,
Jan Stap,
Jaap D. van Buul,
Carlie J.M. de Vries,
Vivian de Waard
Publication year - 2013
Publication title -
arteriosclerosis thrombosis and vascular biology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.007
H-Index - 270
eISSN - 1524-4636
pISSN - 1079-5642
DOI - 10.1161/atvbaha.113.301394
Subject(s) - medicine , kinase , c jun , endothelium , angiotensin ii , pharmacology , inflammation , cancer research , immunology , chemistry , biochemistry , receptor , transcription factor , gene
In aortic aneurysms the arterial vessel wall is dilated because of destruction of its integrity, which may lead to lethal vessel rupture. Chronic infiltration of inflammatory cells into the vessel wall is fundamental to aneurysm pathology. We aim to limit aneurysm growth by inhibition of inflammation and reducing endothelial cell (EC) activation with immunosuppressive drug azathioprine (Aza).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom